Cover Image
市場調查報告書

中國的感染疾病診斷市場預測

China Infectious Diagnostics Market Outlook to 2024

出版商 GlobalData 商品編碼 346059
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
Back to Top
中國的感染疾病診斷市場預測 China Infectious Diagnostics Market Outlook to 2024
出版日期: 2017年11月13日 內容資訊: 英文 144 Pages
簡介

本報告提供中國的感染疾病診斷市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 中國的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 中國的主要企業概要:感染疾病診斷市場

  • 企業概要
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthcare
    • Danaher Corporation
    • Alere Inc.
    • Hologic, Inc.
    • Becton, Dickinson and Company
    • Cepheid
    • Qiagen N.V.
    • DiaSorin S.p.A

第5章 感染疾病診斷市場開發中產品

第6章 財務交易形勢

  • 夥伴關係

第7章 最近的發展

  • 企業宣傳
  • 公佈財報
  • 其他重要的發展

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC2852DB

GlobalData's new report, China Infectious Diagnostics Market Outlook to 2024, provides key market data on the China Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology, Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Infectious Diagnostics market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the China Infectious Diagnostics market.
  • Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Hologic Inc and Siemens Healthcare GmbH.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 8

  • 2.1 What Is This Report About? 8
  • 2.2 Infectious Diagnostics Market Segmentation 8
  • 2.3 Definitions of Markets Covered in the Report 10

3 Infectious Diagnostics Market, China 15

  • 3.1 Infectious Diagnostics Market, China, Revenue ($m), 2010-2017 15
  • 3.2 Infectious Diagnostics Market, China, Revenue ($m), 2017-2024 18
    • 3.2.1 Chlamydia trichomatis Diagnostic Test Kits Market, China, Revenue ($m), by Segment, 2010-2017 21
    • 3.2.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Revenue ($m), by Segment, 2010-2017 23
    • 3.2.3 Hepatitis Test Kits Market, China, Revenue ($m), by Segment, 2010-2017 25
    • 3.2.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Revenue ($m), by Segment, 2010-2017 27
    • 3.2.5 Infectious Diagnostics Multiple Parameter Test Kits Market, China, Revenue ($m), by Segment, 2010-2017 29
    • 3.2.6 Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2010-2017 31
    • 3.2.7 Mycobacterium tuberculosis Diagnostic Tests Market, China, Revenue ($m), by Segment, 2010-2017 33
    • 3.2.8 Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), by Segment, 2010-2017 35
    • 3.2.9 Post Streptococcus pyogenes Diagnostic Tests Market, China, Revenue ($m), by Segment, 2010-2017 37
    • 3.2.10 Retrovirus Tests Market, China, Revenue ($m), by Segment, 2010-2017 39
    • 3.2.11 Treponema pallidum Diagnostic Tests Market, China, Revenue ($m), by Segment, 2010-2017 41
    • 3.2.12 Chlamydia trichomatis Diagnostic Test Kits Market, China, Revenue ($m), by Segment, 2017-2024 43
    • 3.2.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Revenue ($m), by Segment, 2017-2024 45
    • 3.2.14 Hepatitis Test Kits Market, China, Revenue ($m), by Segment, 2017-2024 47
    • 3.2.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Revenue ($m), by Segment, 2017-2024 49
    • 3.2.16 Infectious Diagnostics Multiple Parameter Test Kits Market, China, Revenue ($m), by Segment, 2017-2024 51
    • 3.2.17 Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2017-2024 53
    • 3.2.18 Mycobacterium tuberculosis Diagnostic Tests Market, China, Revenue ($m), by Segment, 2017-2024 55
    • 3.2.19 Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), by Segment, 2017-2024 57
    • 3.2.20 Post Streptococcus pyogenes Diagnostic Tests Market, China, Revenue ($m), by Segment, 2017-2024 59
    • 3.2.21 Retrovirus Tests Market, China, Revenue ($m), by Segment, 2017-2024 61
    • 3.2.22 Treponema pallidum Diagnostic Tests Market, China, Revenue ($m), by Segment, 2017-2024 63
  • 3.3 Infectious Diagnostics Market, China, Volume (Units), 2010-2017 65
  • 3.4 Infectious Diagnostics Market, China, Volume (Units), 2017-2024 68
    • 3.4.1 Chlamydia trichomatis Diagnostic Test Kits Market, China, Volume (Units), by Segment, 2010-2017 71
    • 3.4.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Volume (Units), by Segment, 2010-2017 73
    • 3.4.3 Hepatitis Test Kits Market, China, Volume (Units), by Segment, 2010-2017 75
    • 3.4.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Volume (Units), by Segment, 2010-2017 77
    • 3.4.5 Infectious Diagnostics Multiple Parameter Test Kits Market, China, Volume (Units), by Segment, 2010-2017 79
    • 3.4.6 Infectious Diagnostics Rapid Tests & POC Market, China, Volume (Units), by Segment, 2010-2017 81
    • 3.4.7 Mycobacterium tuberculosis Diagnostic Tests Market, China, Volume (Units), by Segment, 2010-2017 83
    • 3.4.8 Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), by Segment, 2010-2017 85
    • 3.4.9 Post Streptococcus pyogenes Diagnostic Tests Market, China, Volume (Units), by Segment, 2010-2017 87
    • 3.4.10 Retrovirus Tests Market, China, Volume (Units), by Segment, 2010-2017 89
    • 3.4.11 Treponema pallidum Diagnostic Tests Market, China, Volume (Units), by Segment, 2010-2017 91
    • 3.4.12 Chlamydia trichomatis Diagnostic Test Kits Market, China, Volume (Units), by Segment, 2017-2024 94
    • 3.4.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Volume (Units), by Segment, 2017-2024 96
    • 3.4.14 Hepatitis Test Kits Market, China, Volume (Units), by Segment, 2017-2024 98
    • 3.4.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Volume (Units), by Segment, 2017-2024 100
    • 3.4.16 Infectious Diagnostics Multiple Parameter Test Kits Market, China, Volume (Units), by Segment, 2017-2024 102
    • 3.4.17 Infectious Diagnostics Rapid Tests & POC Market, China, Volume (Units), by Segment, 2017-2024 104
    • 3.4.18 Mycobacterium tuberculosis Diagnostic Tests Market, China, Volume (Units), by Segment, 2017-2024 106
    • 3.4.19 Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), by Segment, 2017-2024 108
    • 3.4.20 Post Streptococcus pyogenes Diagnostic Tests Market, China, Volume (Units), by Segment, 2017-2024 110
    • 3.4.21 Retrovirus Tests Market, China, Volume (Units), by Segment, 2017-2024 112
    • 3.4.22 Treponema pallidum Diagnostic Tests Market, China, Volume (Units), by Segment, 2017-2024 114
  • 3.5 Infectious Diagnostics Market, China, Average Price ($), 2010-2024 117
  • 3.6 Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2017 123
  • 3.7 Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2017 124

4 Overview of Key Companies in China, Infectious Diagnostics Market 126

  • 4.1 F. Hoffmann-La Roche Ltd 126
    • 4.1.1 Company Overview 126
  • 4.2 Abbott Laboratories 126
    • 4.2.1 Company Overview 126
  • 4.3 Siemens Healthcare GmbH 126
    • 4.3.1 Company Overview 126
  • 4.4 Cepheid 126
    • 4.4.1 Company Overview 126
  • 4.5 Hologic Inc 127
    • 4.5.1 Company Overview 127
  • 4.6 Qiagen NV 127
    • 4.6.1 Company Overview 127
  • 4.7 Bio-Rad Laboratories Inc 127
    • 4.7.1 Company Overview 127
  • 4.8 Beckman Coulter Inc 127
    • 4.8.1 Company Overview 127
  • 4.9 Alere Inc 128
    • 4.9.1 Company Overview 128
  • 4.10 DiaSorin S.p.A 128
    • 4.10.1 Company Overview 128
  • 4.11 Thermo Fisher Scientific Inc 128
    • 4.11.1 Company Overview 128

5 Infectious Diagnostics Market Pipeline Products 129

6 Financial Deals Landscape 133

  • 6.1 Partnerships 133
    • 6.1.1 iBio Enters into Agreement with TheoremDx 133
    • 6.1.2 Stellar Biotech Terminates Licensing Agreement with University of Guelph 134

7 Recent Developments 135

  • 7.1 Corporate Communications 135
    • 7.1.1 Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 135
    • 7.1.2 Jan 20, 2017: Luke Miels will succeed Abbas Hussain as President, Global Pharmaceuticals, GSK 135
  • 7.2 Legal And Regulatory 136
    • 7.2.1 Jan 13, 2017: Shuwen Biotech Receives EN ISO 13485 Certification 136
  • 7.3 Other Significant Developments 136
    • 7.3.1 Jul 06, 2017: GILUPI: Approval for German Medical Device in China 136
  • 7.4 Strategy And Business Planning 137
    • 7.4.1 Mar 31, 2017: Signaling Continued Investment in China, Bruker Opens Beijing Center of Excellence 137

8 Appendix 138

  • 8.1 Research Methodology 139
    • 8.1.1 Coverage 139
    • 8.1.2 Secondary Research 139
    • 8.1.3 Primary Research 140
    • 8.1.4 Market Modeling and Forecasting 141
    • 8.1.5 Company Share Analysis 142
    • 8.1.6 Distribution Share Analysis 143
    • 8.1.7 Benchmarking 143
  • 8.2 GlobalData Consulting 143
  • 8.3 Contact Us 144
  • 8.4 Disclaimer 144

List of Tables

1.1 List of Tables

  • Table 1: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 16
  • Table 2: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 19
  • Table 3: Chlamydia trichomatis Diagnostic Test Kits Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 22
  • Table 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 24
  • Table 5: Hepatitis Test Kits Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 26
  • Table 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 28
  • Table 7: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 30
  • Table 8: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 32
  • Table 9: Mycobacterium tuberculosis Diagnostic Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 34
  • Table 10: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 36
  • Table 11: Post Streptococcus pyogenes Diagnostic Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 38
  • Table 12: Retrovirus Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 40
  • Table 13: Treponema pallidum Diagnostic Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 42
  • Table 14: Chlamydia trichomatis Diagnostic Test Kits Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 44
  • Table 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 46
  • Table 16: Hepatitis Test Kits Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 48
  • Table 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 50
  • Table 18: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 52
  • Table 19: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 54
  • Table 20: Mycobacterium tuberculosis Diagnostic Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 56
  • Table 21: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 58
  • Table 22: Post Streptococcus pyogenes Diagnostic Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 60
  • Table 23: Retrovirus Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 62
  • Table 24: Treponema pallidum Diagnostic Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 64
  • Table 25: Infectious Diagnostics Market, China, Volume (Units), Historic, 2010-2017 66
  • Table 26: Infectious Diagnostics Market, China, Volume (Units), Forecast, 2017-2024 69
  • Table 27: Chlamydia trichomatis Diagnostic Test Kits Market, China, Volume (Units), Historic, 2010-2017 72
  • Table 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Volume (Units), Historic, 2010-2017 74
  • Table 29: Hepatitis Test Kits Market, China, Volume (Units), Historic, 2010-2017 76
  • Table 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Volume (Units), Historic, 2010-2017 78
  • Table 31: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Volume (Units), Historic, 2010-2017 80
  • Table 32: Infectious Diagnostics Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 82
  • Table 33: Mycobacterium tuberculosis Diagnostic Tests Market, China, Volume (Units), Historic, 2010-2017 84
  • Table 34: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), Historic, 2010-2017 86
  • Table 35: Post Streptococcus pyogenes Diagnostic Tests Market, China, Volume (Units), Historic, 2010-2017 88
  • Table 36: Retrovirus Tests Market, China, Volume (Units), Historic, 2010-2017 90
  • Table 37: Treponema pallidum Diagnostic Tests Market, China, Volume (Units), Historic, 2010-2017 92
  • Table 38: Chlamydia trichomatis Diagnostic Test Kits Market, China, Volume (Units), Forecast, 2017-2024 95
  • Table 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Volume (Units), Forecast, 2017-2024 97
  • Table 40: Hepatitis Test Kits Market, China, Volume (Units), Forecast, 2017-2024 99
  • Table 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Volume (Units), Forecast, 2017-2024 101
  • Table 42: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Volume (Units), Forecast, 2017-2024 103
  • Table 43: Infectious Diagnostics Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 105
  • Table 44: Mycobacterium tuberculosis Diagnostic Tests Market, China, Volume (Units), Forecast, 2017-2024 107
  • Table 45: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), Forecast, 2017-2024 109
  • Table 46: Post Streptococcus pyogenes Diagnostic Tests Market, China, Volume (Units), Forecast, 2017-2024 111
  • Table 47: Retrovirus Tests Market, China, Volume (Units), Forecast, 2017-2024 113
  • Table 48: Treponema pallidum Diagnostic Tests Market, China, Volume (Units), Forecast, 2017-2024 115
  • Table 49: Infectious Diagnostics Market, China, Average Price ($) Historic, 2010-2017 117
  • Table 50: Infectious Diagnostics Market, China, Average Price ($), Forecast, 2017-2024 120
  • Table 51: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 123
  • Table 52: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2017 125
  • Table 53: Infectious Diagnostics Market Pipeline Products 129
  • Table 54: iBio Enters into Agreement with TheoremDx 133
  • Table 55: Stellar Biotech Terminates Licensing Agreement with University of Guelph 134
  • Table 56: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 141

List of Figures

1.2 List of Figures

  • Figure 1: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 15
  • Figure 2: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 18
  • Figure 3: Chlamydia trichomatis Diagnostic Test Kits Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 21
  • Figure 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 23
  • Figure 5: Hepatitis Test Kits Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 25
  • Figure 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 27
  • Figure 7: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 29
  • Figure 8: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 31
  • Figure 9: Mycobacterium tuberculosis Diagnostic Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 33
  • Figure 10: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 35
  • Figure 11: Post Streptococcus pyogenes Diagnostic Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 37
  • Figure 12: Retrovirus Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 39
  • Figure 13: Treponema pallidum Diagnostic Tests Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 41
  • Figure 14: Chlamydia trichomatis Diagnostic Test Kits Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 43
  • Figure 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 45
  • Figure 16: Hepatitis Test Kits Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 47
  • Figure 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 49
  • Figure 18: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 51
  • Figure 19: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 53
  • Figure 20: Mycobacterium tuberculosis Diagnostic Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 55
  • Figure 21: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 57
  • Figure 22: Post Streptococcus pyogenes Diagnostic Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 59
  • Figure 23: Retrovirus Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 61
  • Figure 24: Treponema pallidum Diagnostic Tests Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 63
  • Figure 25: Infectious Diagnostics Market, China, Volume (Units), Historic, 2010-2017 65
  • Figure 26: Infectious Diagnostics Market, China, Volume (Units), Forecast, 2017-2024 68
  • Figure 27: Chlamydia trichomatis Diagnostic Test Kits Market, China, Volume (Units), Historic, 2010-2017 71
  • Figure 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Volume (Units), Historic, 2010-2017 73
  • Figure 29: Hepatitis Test Kits Market, China, Volume (Units), Historic, 2010-2017 75
  • Figure 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Volume (Units), Historic, 2010-2017 77
  • Figure 31: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Volume (Units), Historic, 2010-2017 79
  • Figure 32: Infectious Diagnostics Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 81
  • Figure 33: Mycobacterium tuberculosis Diagnostic Tests Market, China, Volume (Units), Historic, 2010-2017 83
  • Figure 34: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), Historic, 2010-2017 85
  • Figure 35: Post Streptococcus pyogenes Diagnostic Tests Market, China, Volume (Units), Historic, 2010-2017 87
  • Figure 36: Retrovirus Tests Market, China, Volume (Units), Historic, 2010-2017 89
  • Figure 37: Treponema pallidum Diagnostic Tests Market, China, Volume (Units), Historic, 2010-2017 91
  • Figure 38: Chlamydia trichomatis Diagnostic Test Kits Market, China, Volume (Units), Forecast, 2017-2024 94
  • Figure 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, China, Volume (Units), Forecast, 2017-2024 96
  • Figure 40: Hepatitis Test Kits Market, China, Volume (Units), Forecast, 2017-2024 98
  • Figure 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, China, Volume (Units), Forecast, 2017-2024 100
  • Figure 42: Infectious Diagnostics Multiple Parameter Test Kits Market, China, Volume (Units), Forecast, 2017-2024 102
  • Figure 43: Infectious Diagnostics Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 104
  • Figure 44: Mycobacterium tuberculosis Diagnostic Tests Market, China, Volume (Units), Forecast, 2017-2024 106
  • Figure 45: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), Forecast, 2017-2024 108
  • Figure 46: Post Streptococcus pyogenes Diagnostic Tests Market, China, Volume (Units), Forecast, 2017-2024 110
  • Figure 47: Retrovirus Tests Market, China, Volume (Units), Forecast, 2017-2024 112
  • Figure 48: Treponema pallidum Diagnostic Tests Market, China, Volume (Units), Forecast, 2017-2024 114
  • Figure 49: Infectious Diagnostics Market, China, Company Share (%) 2017 124
Back to Top